User login
SAN DIEGO – Dr. Jeffrey L. Saver explains how his trial of in-ambulance magnesium treatment for stroke was both a success and a failure. Magnesium therapy didn’t improve stroke outcomes, but successful administration of treatment within the first "golden hour" after stroke symptoms started paved the way for future trials, giving other potentially neuroprotective agents in the field.
Dr. Bruce Ovbiagele also gives his perspective on the importance of this study in our video interview.
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
SAN DIEGO – Dr. Jeffrey L. Saver explains how his trial of in-ambulance magnesium treatment for stroke was both a success and a failure. Magnesium therapy didn’t improve stroke outcomes, but successful administration of treatment within the first "golden hour" after stroke symptoms started paved the way for future trials, giving other potentially neuroprotective agents in the field.
Dr. Bruce Ovbiagele also gives his perspective on the importance of this study in our video interview.
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
SAN DIEGO – Dr. Jeffrey L. Saver explains how his trial of in-ambulance magnesium treatment for stroke was both a success and a failure. Magnesium therapy didn’t improve stroke outcomes, but successful administration of treatment within the first "golden hour" after stroke symptoms started paved the way for future trials, giving other potentially neuroprotective agents in the field.
Dr. Bruce Ovbiagele also gives his perspective on the importance of this study in our video interview.
